Author/Creator: Enebakk, Terje - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Enebakk, Terje

1. Addition of polyunsaturated fatty acids to statins in familial hypercholesterolemia does not affect in vitro or in vivo endothelial function. (August 2017)

Authors:: Hande, Liv; Thunhaug, Hilde; Enebakk, Terje; Ludviksen, Judith Anita; Hovland, Anders Wilhelm; Lappegård, Knut Tore
Journal:: Atherosclerosis
Issue:: Volume 263(2017)
Page Start:: e43
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of cytokine changes in three different lipoprotein apheresis systems in an ex vivo whole blood model. Issue 2 (29th November 2019)

Authors:: Hardersen, Randolf; Enebakk, Terje; Christiansen, Dorte; Ludviksen, Judith K.; Mollnes, Tom E.; Lappegård, Knut Tore; Hovland, Anders
Journal:: Journal of clinical apheresis
Issue:: Volume 35:Issue 2(2020)
Page Start:: 104
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) – an ex vivo study with blood from a C5‐deficient individual. Issue 4 (25th March 2018)

Authors:: Hardersen, Randolf; Enebakk, Terje; Christiansen, Dorte; Bergseth, Grethe; Brekke, Ole‐Lars; Mollnes, Tom Eirik; Lappegård, Knut Tore; Hovland, Anders
Journal:: Apmis
Issue:: Volume 126:Issue 4(2018)
Page Start:: 342
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol. (August 2016)

Authors:: Lappegård, Knut Tore; Enebakk, Terje; Thunhaug, Hilde; Hovland, Anders
Journal:: Atherosclerosis
Issue:: Volume 251(2016)
Page Start:: 119
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol. (August 2016)

Authors:: Lappegård, Knut Tore; Enebakk, Terje; Thunhaug, Hilde; Hovland, Anders
Journal:: Atherosclerosis
Issue:: Volume 251(2016)
Page Start:: 119
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗